Evidence map›Paper›PMID 18496848›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2008

A long-term flow cytometry assay to analyze the role of specific genes of Drosophila melanogaster S2 cells in surviving genotoxic stress.

Xia Yi, Willy Lemstra, Michel J Vos, Yongfeng Shang, Harm H Kampinga, Tin Tin Su, Ody C M Sibon

Abstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xia YiDepartment of Radiation and Stress Cell Biology, Division of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Willy Lemstra
Michel J Vos
Yongfeng Shang
Harm H Kampinga
Tin Tin Su
Ody C M Sibon

Funding

Cell Cycle Regulation by Checkpoints in DrosophilaR01GM066441 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI SU, TIN TIN · 2002 to 2006
$1.4M
NIGMS NIH HHS GM66441NIGMS NIH HHS R01 GM066441
6 · The paper itself

Abstract

Drosophila S2 cells are easy to manipulate and culture and are a versatile model system for high-throughput screens such as genome-wide siRNA screens to find genes involved in stress or therapy resistance or for screening through large compound libraries to identify cytotoxins. Clonogenic assays are considered the gold-standard to investigate the cytotoxicity of specific treatments or to compare the sensitivity of various cell types for a specific treatment. However, this assay cannot be used for Drosophila S2 cells as they are virtually unable to grow in distinct colonies. We designed a novel fluorescence-based flow cytometry assay to study long-term proliferation of S2 cells under various conditions and in the presence of specific gene products or after downregulation of specific gene products. Here we validate this assay and we used this novel method to investigate the role of checkpoint genes grapes/Dchk1 and DmChk2 in cell survival responses. Our data demonstrate that Grapes/Dchk1 but not DmChk2 is required to survive hydroxyurea. Our assay will be of use to investigate the long-term effects of various treatments in S2 cells and to evaluate the role of specific proteins therein.

Indexed as

Gene Expression RegulationAnimalsCell LineCell ProliferationCell SeparationCell SurvivalDNA DamageDrosophila melanogasterDrosophila ProteinsFlow CytometryGene SilencingGreen Fluorescent ProteinsMutagensRNA InterferenceDrosophila ProteinsGreen Fluorescent ProteinsMutagens

Identifiers

PMID18496848
PMCPMC2579795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.